Zobrazeno 1 - 10
of 15
pro vyhledávání: '"T G, Brott"'
Autor:
Y, Erben, K M, Barrett, W D, Freeman, M, Lin, R, Tawk, C T, Ball, V S, Melton, L M, Thuro, A G, Hakaim, T G, Brott, J F, Meschia
Publikováno v:
Neurocritical care. 32(3)
A relationship between intracranial and abdominal aortic aneurysms (AAA) has been appreciated through genome-wide association studies suggesting a shared pathophysiology. However, the actual prevalence of AAA in patients presenting with ruptured intr
Autor:
T. G. Brott, M. Vinall
Publikováno v:
MD Conference Express. 11:6-8
Autor:
E. C. Haley, C. A. Lewandowski, John R. Marler, T. G. Brott, M. Lu, J. C. Grotta, P. C. Lyden, Joseph P. Broderick, S. H. Horowitz, T. P. Kwiatkowski, B. C. Tilley, Steven R. Levine, M. P. Frankel
Publikováno v:
Neurology. 55:1649-1655
Background: The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study showed a similar percentage of intracranial hemorrhage and good outcome in patients 3 months after stroke treatment given 0 to 90 minutes and 91 to 180
Autor:
T. G. Brott, Carolyn Apperson Hansen, William G. Barsan, Gail L. Kongable, J. R. Marler, Joseph P. Broderick, E. C. Haley, J. Spilker, S Massey, George L. Sheppard
Publikováno v:
Stroke. 24:1000-1004
Early thrombolytic therapy with recombinant tissue-type plasminogen activator is a theoretically attractive approach to the treatment of acute focal cerebral ischemia. In preparation for a larger multicenter trial, three centers piloted a protocol fo
Autor:
James C. Torner, M. C. W. Wong, E. C. Haley, T. G. Brott, J. R. Marler, George L. Sheppard, D. E. Levy, Gail L. Kongable
Publikováno v:
Stroke. 23:641-645
Renewed interest in thrombolytic therapy as potential treatment for patients with acute ischemic stroke prompted a dose-escalation safety study of tissue plasminogen activator in patients with very early (less than or equal to 90 minutes; see Part I)
Autor:
L, Derex, T A, Tomsick, T G, Brott, C A, Lewandowski, M R, Frankel, W, Clark, S, Starkman, J, Spilker, G J, Udsten, J, Khoury, J C, Grotta, J P, Broderick
Publikováno v:
AJNR Am J Neuroradiol
BACKGROUND AND PURPOSE: Follow-up imaging data from stroke patients without angiographically apparent arterial occlusions at symptom onset are lacking. We reviewed our Emergency Management of Stroke (EMS) trial experience to determine the clinical an
Autor:
S C, Fagan, L B, Morgenstern, A, Petitta, R E, Ward, B C, Tilley, J R, Marler, S R, Levine, J P, Broderick, T G, Kwiatkowski, M, Frankel, T G, Brott, M D, Walker
Publikováno v:
Neurology. 50(4)
Tissue plasminogen activator (tPA) has been shown to improve 3-month outcome in stroke patients treated within 3 hours of symptom onset. The costs associated with this new treatment will be a factor in determining the extent of its utilization. Data
Publikováno v:
Archives of neurology. 54(12)
To develop an approach for reducing time between emergency department (ED) admission and treatment in patients with acute ischemic stroke to meet the challenge of providing tissue plasminogen activator treatment within 180 minutes.An observational st
Publikováno v:
Archives of internal medicine. 157(16)
Neurological involvement is a significant cause of morbidity and mortality in patients with sarcoidosis. Detection and management of neurosarcoidosis remains problematic. Our interest in immunosuppressive agents for chronic sarcoidosis has given us e
Publikováno v:
AJNR Am J Neuroradiol
We report staged embolization and stereotactic radiation in a true adult choroidal vein of Galen malformation. Management dilemmas and their resolutions are also discussed.